These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8736067)

  • 1. Chemical defibrillation in acute myocardial ischaemia: a hypothesis.
    Curtis MJ
    J Basic Clin Physiol Pharmacol; 1994; 5(1):1-17. PubMed ID: 8736067
    [No Abstract]   [Full Text] [Related]  

  • 2. Tedisamil. KC 8857.
    Drugs R D; 1999 Apr; 1(4):327-30. PubMed ID: 10566055
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of tedisamil (KC-8857) on cardiac electrophysiology and ventricular fibrillation in the rabbit isolated heart.
    Chi L; Park JL; Friedrichs GS; Banglawala YA; Perez MA; Tanhehco EJ; Lucchesi BR
    Br J Pharmacol; 1996 Mar; 117(6):1261-9. PubMed ID: 8882624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation: emerging possibilities for drug treatment: an overview of current opportunities and recent developments.
    Papp JG; Singh BN
    J Cardiovasc Pharmacol Ther; 2003 Jun; 8 Suppl 1():S1-3. PubMed ID: 12746746
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined administration of an IK(ATP) activator and Ito blocker increases coronary flow independently of effects on heart rate, QT interval, and ischaemia-induced ventricular fibrillation in rats.
    Rees SA; Tsuchihashi K; Hearse DJ; Curtis MJ
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):343-9. PubMed ID: 7504122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic pantoprazole administration and ischemia--reperfusion arrhythmias in vivo in rats--antiarrhythmic or arrhythmogenic?
    Abdel-Kawy HS
    Cardiovasc Ther; 2015 Apr; 33(2):27-34. PubMed ID: 25677801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of tedisamil on the initiation and maintenance of ventricular fibrillation: chemical defibrillation by Ito blockade?
    Tsuchihashi K; Curtis MJ
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):445-56. PubMed ID: 1720845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of the antiarrhythmic properties of eicosanoid inhibitors, free radical scavengers and potassium channel blockers on reperfusion induced arrhythmias in the rat.
    Beatch GN; Courtice ID; Salari H
    Proc West Pharmacol Soc; 1989; 32():285-9. PubMed ID: 2780604
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel antiarrhythmic drugs in atrial fibrillation: focus on tedisamil.
    Krishnamoorthy S; Lip GY
    Expert Opin Investig Drugs; 2009 Aug; 18(8):1191-6. PubMed ID: 19604120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tedisamil increases coherence during ventricular fibrillation and decreases defibrillation energy requirements.
    Dorian P; Newman D
    Cardiovasc Res; 1997 Feb; 33(2):485-94. PubMed ID: 9074714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further studies into the ECG effects of tedisamil (KC 8857) in rats.
    Howard PG; Abraham S; Courtice ID; Walker MJ
    Proc West Pharmacol Soc; 1989; 32():183. PubMed ID: 2780585
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of nicorandil on electrophysiological changes in acute myocardial ischemia and reperfusion.
    Shinohara H; Nishikado A; Wakatsuki T; Sakabe K; Ito S
    Jpn Heart J; 1998 May; 39(3):363-73. PubMed ID: 9711188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of a mouse in vitro model of ischaemia-induced ventricular fibrillation.
    Stables CL; Curtis MJ
    Cardiovasc Res; 2009 Jul; 83(2):397-404. PubMed ID: 19228704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic drug therapy of atrial fibrillation: focus on new agents.
    Dorian P
    J Cardiovasc Pharmacol Ther; 2003 Jun; 8 Suppl 1():S27-31. PubMed ID: 12746749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart.
    Farkas A; Qureshi A; Curtis MJ
    Br J Pharmacol; 1999 Sep; 128(1):41-50. PubMed ID: 10498833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tedisamil (Solvay).
    Flores NA
    Curr Opin Investig Drugs; 2001 Jan; 2(1):97-103. PubMed ID: 11527020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The mechanism of the action of dalargin in experimental myocardial ischemia].
    Mikhaĭlova SD; Storozhakov GI; Bebiakova NA; Glushchenko NV; Semushkina TM
    Biull Eksp Biol Med; 1992 Oct; 114(10):345-7. PubMed ID: 1288681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of taurine against reperfusion-induced arrhythmias in isolated ischemic rat heart.
    Chahine R; Feng J
    Arzneimittelforschung; 1998 Apr; 48(4):360-4. PubMed ID: 9608877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment of BAPTA-AM suppresses the genesis of repetitive endocardial focal discharges and pacing-induced ventricular arrhythmia during global ischemia.
    Wu TJ; Lin SF; Hsieh YC; Lin TC; Lin JC; Ting CT
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1154-62. PubMed ID: 21489030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive Effect of Canstatin against Ventricular Arrhythmia Induced by Ischemia/Reperfusion Injury: A Pilot Study.
    Sugiyama A; Shimizu Y; Okada M; Otani K; Yamawaki H
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.